The value of surrogate endpoints for predicting real-world survival across five cancer types

You can find one of my recent papers measuring how well survival measures from clinical trials (i.e., overall survival, progression free survival, time to progression) translate into real-world survival outcomes in Current Medical Research and Opinion here.  The abstract is below.   Objective It is unclear how well different outcome measures in randomized controlled trials (RCTs) perform in…